Reaction

Acute Myeloid Leukaemia Recurrent reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,103 reports · 71 co-occurring drugs

As of the last recalculation, Acute Myeloid Leukaemia Recurrent appears in 2,103 FAERS reports alongside 71 co-occurring drug terms. The strongest observed disproportionality signal is AZACITIDINE FOR (PRR 314.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Azacitidine For	454	314.8	322.9
Azacitidine	606	283.6	289.5
Busulfan	263	188.9	192.1
Anti-Thymocyte Globulin (Rabbit)	112	145.1	147.1
Venetoclax	602	135.2	136.5
Fludarabine Phosphate	423	133.0	134.5
Posaconazole Delayed-Release	131	125.8	127.4
Cytarabine	487	104.1	104.9
Posaconazole	155	101.8	102.8
Micafungin Sodium	53	63.4	63.8
Sorafenib	118	59.5	59.9
Filgrastim	185	53.3	53.5
Cladribine	30	31.3	31.4
Voriconazole	89	30.2	30.3
Voriconazole Injection	64	30.1	30.1
Itraconazole	34	29.3	29.4
Cefepime Hydrochloride	40	25.0	25.1
Cyclosporine	225	22.3	22.3
Thiotepa	21	22.0	22.0
Alemtuzumab	42	21.9	22.0
Melphalan Hydrochloride	52	21.0	21.1
Etoposide	131	18.7	18.8
Melphalan	42	18.6	18.7
Meropenem	57	18.0	18.1
Tacrolimus Ointment 0.1%	203	17.8	17.8
Tacrolimus Extended-Release Capsules	203	17.7	17.7
Hydroxyurea	37	17.6	17.6
Amphotericin B	22	17.6	17.6
Tacrolimus	242	17.2	17.2
Tretinoin	13	15.9	16.0
Mycophenolate Mofetil	199	15.9	15.9
Mycophenolate Mofetil Hydrochloride	199	15.9	15.9
Imatinib	27	15.3	15.4
Moxifloxacin	20	14.2	14.2
Ganciclovir	14	13.6	13.6
Granisetron Hydrochloride	14	13.3	13.4
Cyclophosphamide Injection, Solution	215	13.3	13.3
Cyclophosphamide	215	13.3	13.3
Cyclophosphamide For Injection	215	13.3	13.3
Ganciclovir Sodium	14	13.2	13.2
Fluconazole	88	12.9	12.9
Hydrocortisone Sodium Succinate	11	11.6	11.6
Atovaquone	9	11.1	11.1
Acyclovir	116	10.6	10.6
Prednisolone Acetate	11	10.6	10.6
Basiliximab	12	10.2	10.2
Moxifloxacin Hydrochloride	20	9.8	9.9
Febuxostat Tablets 40 Mg	10	9.8	9.8
Febuxostat Tablets 80 Mg	10	9.8	9.8
Ursosiol	19	9.8	9.8
Daptomycin	9	9.7	9.7
Ursodiol	20	9.2	9.2
Levofloxacin	49	8.2	8.2
Levofloxacin In 5% Dextrose	49	8.2	8.2
Cefepime	11	7.6	7.6
Blinatumomab	8	7.6	7.6
Deferasirox	20	7.5	7.5
Valacyclovir	30	7.2	7.2
Phenytoin	15	7.2	7.2
Piperacillin Sodium,Tazobactam Sodium	18	6.8	6.8
Ruxolitinib	47	6.6	6.6
Vancomycin Hydrochloride	40	6.1	6.1
Mesna Injection	5	6.0	6.0
Valacyclovir Hydrochloride	42	6.0	6.0
Febuxostat	10	5.9	5.9
Sirolimus	8	5.9	5.9
Mesna	5	5.9	5.9
Linezolid	14	4.7	4.7
Romiplostim	6	4.0	4.0
Acalabrutinib	4	3.3	3.3
Remdesivir	4	3.0	3.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.